All News about Revance Therapeutics![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]()
Analyst Expectations for Revance Therapeutics's Future
June 07, 2023
Via Benzinga
![]()
Earnings Preview For Revance Therapeutics
May 08, 2023
Via Benzinga
![]()
7 Analysts Have This to Say About Revance Therapeutics
April 11, 2023
Via Benzinga
What 4 Analyst Ratings Have To Say About Revance Therapeutics
January 24, 2023
Via Benzinga
![]() Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Revance to Participate in Upcoming Investor Conferences
March 07, 2023
Via Business Wire
![]() ![]() ![]() ![]()
Revance to Participate in the 43rd Annual Cowen Healthcare Conference
February 27, 2023
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 11, 2023
Via Benzinga
![]() ![]()
12 Health Care Stocks Moving In Monday's Intraday Session
January 09, 2023
Via Benzinga
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Revance Therapeutics (NQ: RVNC )All News about Revance Therapeutics
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|